Immunoengineering panel discussion: Industry-academic synergies

preview_player
Показать описание
A panel discussion moderated by Shann Yu, scientific director of the Chicago Immunoengineering Innovation Center, featuring:

-Jay Cui, PhD’09, MBA’15, principal at Abingworth Management
-Jeffrey Hubbell, Eugene Bell Professor in Tissue Engineering and vice dean and executive officer
-Jasmina Marjanovic, PhD’10, director at Abbvie Ventures
-Paul Song, co-founder and CEO of Fuse Therapeutics & Virafuse Biotherapeutics.

This event was part of a larger celebration of the Pritzker School of Molecular Engineering's (PME) 10th anniversary.

About PME:
The Pritzker School of Molecular Engineering at the University of Chicago integrates science and engineering to address global challenges from the molecular level up. Our work applies molecular-level science to the design of advanced devices, processes, and technologies. Organized by interdisciplinary research themes, we aim to develop solutions to urgent societal problems, such as water and energy resources, information security, and human health.

Follow #UChicagoPME online:
Рекомендации по теме